<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>Wyeth Pharmaceuticals - PRWeb Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/409864.xml</link>
<description>Wyeth Pharmaceuticals - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>FDA Approves Pristiq for the Treatment of Adult Patients with Major Depressive Disorder</title>
     <link>http://www.prweb.com/releases/2008/03/prweb735364.htm</link><description>   <![CDATA[ <P>The FDA has approved PRISTIQ (desvenlafaxine), an SNRI, to treat adult patients with major depressive disorder (MDD). Wyeth expects to begin shipping PRISTIQ to wholesalers beginning in the second quarter of 2008. (PRWeb Mar 1, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/03/prweb735364.htm">http://www.prweb.com/releases/2008/03/prweb735364.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2008/03/prweb735364.htm</guid>
        </item>
</channel>
</rss>